Reporting Requirements, Section 340B, Medicare

CMS CY 2026 proposed rules: 340B in PFS and OPPS

McDermott Will & Emery on 7/23/2025

On July 15, 2025, the Centers for Medicare & Medicaid Services (CMS) released the CY 2026 Outpatient Prospective Payment System (OPPS) proposed rule. The proposed rule includes a provision that would increase the reduction in...more

5 Questions with Sayeh Nikpay: The 340B Drug Pricing Program

Cornerstone Research on 2/8/2024

A periodic feature by Cornerstone Research, in which our affiliated experts, senior advisors, and professionals, talk about their research and findings. We interview Professor Sayeh Nikpay of the School of Public Health,...more

Government Continues to Explore Role of 340B Contract Pharmacies

Goodwin on 9/15/2023

The 340B Drug Pricing Program (the “Program”) allows certain healthcare providers (“covered entities”) to purchase pharmaceuticals from drug manufacturers at discounted rates. Some covered entities do not have an internal...more

March 2019: Where Are We Now With 340B?

Mintz - Health Care Viewpoints on 3/5/2019

Long time readers of our blog may recall that five years ago, I predicted that 2014 might be a game-changing year for the 340B Drug Discount Program. 2014 saw attempts at regulatory changes, but a successful court challenge...more

Six Initiatives States May Pursue to Curb Drug Prices and the 340B Factor

Mintz - Health Care Viewpoints on 10/24/2018

For much of the past 18 months, the Trump Administration, and in particular CMS, have talked a good game regarding reducing pharmaceutical prices. On October 16, 2018, a key component of the Administration’s strategy was...more

Six Key Follow-Up Questions Asked by Congress in 340B Hearing

Mintz - Health Care Viewpoints on 11/2/2017

Earlier this month the House Energy and Commerce Committee’s subcommittee on Government Oversight and Investigations held its second hearing on the 340B Drug Discount Program. The hearing followed on the heels of a July 18th...more